Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial update on Total Body Irradiation with or without Total Lymphoid Irradiation and Anti-Thymocyte Globulin in non-myeloablative h…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Unrelated Umbilical Cord Blood (UBC)Transplantation [NA]
Clinical trial update for unrelated umbilical cord blood transplantation; the study is completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma [Phase 2]
Phase 2 trial update of Ofatumumab plus Fresh Frozen Plasma in patients with chronic lymphocytic leukemia. Results posted; study completed.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell [Phase 1]
Phase 1 study updating on CAR-20/19-T cells in relapsed/refractory B-cell lymphomas; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating ruxolitinib phosphate in previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for an anti-CD19 CAR-T cell therapy in B cell malignancies has completed recruiting.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial in Japanese participants assessing safety, tolerability, and pharmacokinetics of idelalisib in relapsed or refractory indolent…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 study evaluating idelalisib in combination with various chemotherapeutic, immunomodulatory agents, and anti-CD20 antibody in relapse…
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155) [Phase 1]
Phase 1 study of pembrolizumab in combination with dinaciclib in hematologic malignancies was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL [Phase 1, Phase 2]
Phase 1/2 study of TP-0903 (AXL inhibitor) in previously treated chronic lymphocytic leukemia was terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 trial evaluating a combination of ibrutinib, obinutuzumab, and venetoclax in patients with B-cell chronic lymphocytic leukemia, in…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL [Phase 1]
Phase 1 study evaluating tirabrutinib as monotherapy in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia has comple…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial update of alemtuzumab and ofatumumab in previously untreated symptomatic chronic lymphocytic leukemia; results have been poste…
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis [Phase 2]
Phase 2 trial evaluating lenalidomide to enhance immune response to vaccine therapy in patients with chronic lymphocytic leukemia, small lym…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial evaluating idelalisib in combination with BI 836826 in chronic lymphocytic leukemia has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [Phase 2]
Phase 2 trial evaluating Ofatumumab in combination with methylprednisolone or with lenalidomide in relapsed/refractory CLL/SLL has completed…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL [Phase 2]
Phase II trial evaluating alemtuzumab and rituximab in patients with previously untreated chronic lymphocytic leukemia has completed with re…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia. [Phase 2]
Phase 2 trial assessing frontline fludarabine, cyclophosphamide, and ofatumumab chemoimmunotherapy in young patients with B-cell lymphoid le…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL [Phase 2]
Phase II clinical trial evaluating the combination of ibrutinib and short-course fludarabine in treatment-naive chronic lymphocytic leukemia…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of zanubrutinib in relapsed or refractory chronic lymphocytic leukemia and small lymphocy…
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies [Phase 2]
Phase 2 study evaluating entospletinib in adults with relapsed or refractory hematologic malignancies; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases [Phase 2]
Phase 2 trial evaluating myeloablative umbilical cord blood transplantation in various hematological diseases has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig [Phase 2, Phase 3]
Phase 2/3 trial update evaluating humoral immunodeficiency in chronic lymphocytic leukemia (CLL) and therapy with subcutaneous immunoglobuli…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL) [Phase 1]
Phase 1 dose-escalation trial of BI836826 in relapsed chronic lymphocytic leukemia (CLL) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 clinical trial of UC-961 (cirmtuzumab) in relapsed or refractory chronic lymphocytic leukemia has completed with results posted.